209 related articles for article (PubMed ID: 18983965)
21. Generation of multipotential mesendodermal progenitors from mouse embryonic stem cells via sustained Wnt pathway activation.
Bakre MM; Hoi A; Mong JC; Koh YY; Wong KY; Stanton LW
J Biol Chem; 2007 Oct; 282(43):31703-12. PubMed ID: 17711862
[TBL] [Abstract][Full Text] [Related]
22. DNA synthesis is required for reprogramming mediated by stem cell fusion.
Tsubouchi T; Soza-Ried J; Brown K; Piccolo FM; Cantone I; Landeira D; Bagci H; Hochegger H; Merkenschlager M; Fisher AG
Cell; 2013 Feb; 152(4):873-83. PubMed ID: 23415233
[TBL] [Abstract][Full Text] [Related]
23. Identification of Oct4-activating compounds that enhance reprogramming efficiency.
Li W; Tian E; Chen ZX; Sun G; Ye P; Yang S; Lu D; Xie J; Ho TV; Tsark WM; Wang C; Horne DA; Riggs AD; Yip ML; Shi Y
Proc Natl Acad Sci U S A; 2012 Dec; 109(51):20853-8. PubMed ID: 23213213
[TBL] [Abstract][Full Text] [Related]
24. Tuning of β-catenin activity is required to stabilize self-renewal of rat embryonic stem cells.
Meek S; Wei J; Sutherland L; Nilges B; Buehr M; Tomlinson SR; Thomson AJ; Burdon T
Stem Cells; 2013 Oct; 31(10):2104-15. PubMed ID: 23843312
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of anti-Wnt/β-catenin signaling agents by pGL4-TOP transfected stable cells with a luciferase reporter system.
Chuang KA; Lieu CH; Tsai WJ; Wu MH; Chen YC; Liao JF; Wang CC; Kuo YC
Braz J Med Biol Res; 2010 Oct; 43(10):931-41. PubMed ID: 20835687
[TBL] [Abstract][Full Text] [Related]
26. Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog.
Moon JH; Yun W; Kim J; Hyeon S; Kang PJ; Park G; Kim A; Oh S; Whang KY; Kim DW; Yoon BS; You S
Biochem Biophys Res Commun; 2013 Feb; 431(3):444-9. PubMed ID: 23333380
[TBL] [Abstract][Full Text] [Related]
27. Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells.
Ueno S; Weidinger G; Osugi T; Kohn AD; Golob JL; Pabon L; Reinecke H; Moon RT; Murry CE
Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9685-90. PubMed ID: 17522258
[TBL] [Abstract][Full Text] [Related]
28. Segregation of myoblast fusion and muscle-specific gene expression by distinct ligand-dependent inactivation of GSK-3β.
Pansters NA; van der Velden JL; Kelders MC; Laeremans H; Schols AM; Langen RC
Cell Mol Life Sci; 2011 Feb; 68(3):523-35. PubMed ID: 20694829
[TBL] [Abstract][Full Text] [Related]
29. beta-Galactosidase enzyme fragment complementation for the measurement of Wnt/beta-catenin signaling.
Verkaar F; Blankesteijn WM; Smits JF; Zaman GJ
FASEB J; 2010 Apr; 24(4):1205-17. PubMed ID: 19940259
[TBL] [Abstract][Full Text] [Related]
30. Activation of Wnt/beta-catenin signaling increases insulin sensitivity through a reciprocal regulation of Wnt10b and SREBP-1c in skeletal muscle cells.
Abiola M; Favier M; Christodoulou-Vafeiadou E; Pichard AL; Martelly I; Guillet-Deniau I
PLoS One; 2009 Dec; 4(12):e8509. PubMed ID: 20041157
[TBL] [Abstract][Full Text] [Related]
31. Reprogramming of somatic cells after fusion with induced pluripotent stem cells and nuclear transfer embryonic stem cells.
Sumer H; Jones KL; Liu J; Heffernan C; Tat PA; Upton KR; Verma PJ
Stem Cells Dev; 2010 Feb; 19(2):239-46. PubMed ID: 19637940
[TBL] [Abstract][Full Text] [Related]
32. Oct4 was a novel target of Wnt signaling pathway.
Li J; Li J; Chen B
Mol Cell Biochem; 2012 Mar; 362(1-2):233-40. PubMed ID: 22120493
[TBL] [Abstract][Full Text] [Related]
33. Temporal perturbation of the Wnt signaling pathway in the control of cell reprogramming is modulated by TCF1.
Aulicino F; Theka I; Ombrato L; Lluis F; Cosma MP
Stem Cell Reports; 2014 May; 2(5):707-20. PubMed ID: 24936456
[TBL] [Abstract][Full Text] [Related]
34. Cytoplast containing reprogramming-related factors from human embryonic stem cells arrested at metaphase.
Du L; Lin G; Lu G
Dev Growth Differ; 2011 Jan; 53(1):18-25. PubMed ID: 21261607
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxicity and activation of the Wnt/beta-catenin pathway in mouse embryonic stem cells treated with four GSK3 inhibitors.
Naujok O; Lentes J; Diekmann U; Davenport C; Lenzen S
BMC Res Notes; 2014 Apr; 7():273. PubMed ID: 24779365
[TBL] [Abstract][Full Text] [Related]
36. Reprogramming of Extraembryonic Trophoblast Stem Cells into Embryonic Pluripotent State by Fusion with Embryonic Stem Cells.
Hong YJ; Hong K; Byun S; Choi HW; Do JT
Stem Cells Dev; 2018 Oct; 27(19):1350-1359. PubMed ID: 29993328
[TBL] [Abstract][Full Text] [Related]
37. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor.
Sato N; Meijer L; Skaltsounis L; Greengard P; Brivanlou AH
Nat Med; 2004 Jan; 10(1):55-63. PubMed ID: 14702635
[TBL] [Abstract][Full Text] [Related]
38. WNTing embryonic stem cells.
Wray J; Hartmann C
Trends Cell Biol; 2012 Mar; 22(3):159-68. PubMed ID: 22196214
[TBL] [Abstract][Full Text] [Related]
39. Ectopic γ-catenin expression partially mimics the effects of stabilized β-catenin on embryonic stem cell differentiation.
Mahendram S; Kelly KF; Paez-Parent S; Mahmood S; Polena E; Cooney AJ; Doble BW
PLoS One; 2013; 8(5):e65320. PubMed ID: 23724138
[TBL] [Abstract][Full Text] [Related]
40. Dual roles of Oct4 in the maintenance of mouse P19 embryonal carcinoma cells: as negative regulator of Wnt/β-catenin signaling and competence provider for Brachyury induction.
Marikawa Y; Tamashiro DA; Fujita TC; Alarcon VB
Stem Cells Dev; 2011 Apr; 20(4):621-33. PubMed ID: 21083502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
